Antibacterial activity of green silver nanoparticles synthesized from Anogeissus acuminata against multidrug resistant urinary tract infecting bacteria in vitro and host-toxicity testing

2018 ◽  
Vol 16 (2) ◽  
pp. 120-125 ◽  
Author(s):  
Monali P. Mishra ◽  
Rabindra N. Padhy
Keyword(s):  
Silver Nanoparticles ◽  
Antibacterial Activity ◽  
Urinary Tract ◽  
Toxicity Testing ◽  
Multidrug Resistant

scholarly journals In-vitro antibacterial activity of Rhus javanica against multidrug-resistant uro-pathogens

2019 ◽  
Vol 7 (1) ◽  
pp. 41-46
Author(s):  
Bhavan Saud ◽  
T. Paudel ◽  
T. Sharma ◽  
M. Gyawali ◽  
G. Dhungana ◽  
...  
Keyword(s):  
Urinary Tract Infection ◽  
Antibacterial Activity ◽  
Urinary Tract ◽  
Tract Infection ◽  
Pathogenic Bacteria ◽  
Susceptibility Testing ◽  
Bacterial Pathogens ◽  
Multidrug Resistant ◽  
Health Concern

Background and Objectives: Antibiotic resistance is emerging as a major public health concern. From the ancient time in history, different plants and herbs have been known to have medicinal value. Rhus javanica has been found to show antibacterial activity against pathogenic bacteria. Thus, present study is designed to investigate the prevalence of urinary tract infection causing bacterial pathogens, its antibiogram and effect of Rhus javanica in standard in-vitro condition against multidrug-resistant. Material and Methods: Cross-sectional study was conducted in urinary tract infection suspected patients visiting a clinic in Kalimati, Kathmandu, from July to December 2017. A total of 133 midstream urine samples were collected and cultured in MacConkey agar and Blood agar media and isolates were identified by standard biochemical tests. Antibiotic susceptibility testing was performed according to Clinical and Laboratory Standard Institute (CLSI) guideline. Leaves extract of Rhus javanica was obtained by maceration using 50.0% methanol and susceptibility testing was performed by using cork borer method in Mueller-Hinton agar. Results: Out of total 133 samples, 35.3%showed significant bacterial growth (i.e. 105 cfu/ml) on agar plate. The most predominant organism was Escherichia coli 17.3%, followed by Enterococcus faecalis 6.8%, Klebsiella pneumoniae 3.8%, Pseudomonas aeruginosa 3.0%, Proteus vulgaris 2.3%, and Staphylococcus aureus 2.3%. Out of 47 isolates, 53.2% were Multi Drug Resistant (MDR). Various concentrations of the crude extract used (25, 50, 75 and 100 mg/ml) showed susceptibility to all the bacterial pathogens isolated, with the diameter of zone of inhibition ranging from 12 to 28 mm. Conclusion: Methanolic extract of Rhus javanica showed antibacterial activity against multidrug-resistant isolates of bacterial uropathogens in standard in-vitro condition.

scholarly journals IN VITRO ANTIBACTERIAL EFFICACY OF PLECTRANTHUS AMBOINICUS MEDIATED SILVER NANOPARTICLES AGAINST URINARY TRACT PATHOGENS

2019 ◽  
pp. 153-159
Author(s):  
SREELAKSHMY S ◽  
THANGAPANDIYAN S
Keyword(s):  
Silver Nanoparticles ◽  
Antibacterial Activity ◽  
Urinary Tract ◽  
Leaf Extract ◽  
Spherical Shape ◽  
Plate Count ◽  
Dilution Method ◽  
Klebsiella Pneumonia ◽  
Plectranthus Amboinicus

Objective: The objective of the present study is to synthesize green mediated silver nanoparticles (AgNPs) using Plectranthus amboinicus leaf extract and to evaluate its antibacterial activity against selected urinary tract infection (UTI) causing bacteria. Methods: Phytoconstituents present in leaf extract of P. amboinicus (Lour.) Spreng were analyzed by standard qualitative tests. The synthesized AgNPs were characterized by visual inspection, ultraviolet-visible spectroscopy, Fourier transform infrared spectroscopy, X-ray diffraction, scanning electron microscopy, and energy dispersive spectroscopy. The antibacterial activity of synthesized AgNPs was examined against the UTI pathogens such as Pseudomonas aeruginosa, Enterobacter sp., Klebsiella pneumonia, and Escherichia coli. The minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of AgNPs were carried out by broth dilution method and standard plate count method, respectively. Results: Synthesized AgNPs exhibited a spherical shape with an average size of 17.3 nm. The antibacterial activity of AgNPs against tested bacterial pathogens showed a maximum inhibition zone of 22.00±1.00 mm against P. aeruginosa. The bacterial growth inhibition was confirmed by MIC and MBC. Conclusion: P. amboinicus leaf extract mediated AgNPs could be used as an effective antibacterial agent for the management of UTIs. Surface modifications of urinary catheters with AgNPs may prevent the risk of contamination and the associated infections.

scholarly journals In-vitro Antibacterial activity of Rhus javanica Against Multidrug-Resistant Uropathogens

2020 ◽  
Vol 2 (1) ◽  
Keyword(s):  
Urinary Tract Infection ◽  
Antibacterial Activity ◽  
Urinary Tract ◽  
Tract Infection ◽  
Pathogenic Bacteria ◽  
Bacterial Pathogens ◽  
Agar Plate ◽  
Multidrug Resistant ◽  
Health Concern

Background and objective: Antibiotic resistance is emerging as a major public health concern. From the ancient time in history, different plants and herbs have been known to have medicinal value. Rhus javanica has been found to show antibacterial activity against pathogenic bacteria. Thus, present study is designed to investigate the prevalence of urinary tract infection causing bacterial pathogens, its antibiogram and effect of Rhus javanica in standard in-vitro condition against multidrug-resistant. Materials and Methods: Cross-sectional study was conducted in urinary tract infection suspected patients visiting a clinic in Kalimati, Kathmandu, from August to October 2019. A total of 133 midstream urine samples were collected and cultured in MacConkey agar and Blood agar media and isolates were identified by standard biochemical tests. Antibiotic susceptibility testing was performed according to Clinical and Laboratory Standard Institute (CLSI) guideline. Leaves extract of Rhus javanica was obtained by maceration using 50.0% methanol andsusceptibility testing was performed by using cork borer method in Mueller-Hinton agar. Results: Out of total 133 samples, 35.3%showed significant bacterial growth (i.e. 105 cfu/ml) on agar plate. The most predominant organism was Escherichia coli 17.3%, followed by Enterococcus faecalis 6.8%, Klebsiella pneumoniae 3.8%, Pseudomonas aeruginosa 3.0%, Proteus vulgaris 2.3%, and Staphylococcus aureus 2.3%. Out of 47 isolates, 53.2% were Multi Drug Resistant (MDR). Various concentrations of the crude extract used (25, 50, 75 and 100 mg/ml) showed susceptibility to all the bacterial pathogens isolated, with the diameter of zone of inhibition ranging from 12 to 28 mm. Conclusion: Methanolic extract of Rhus javanica showed antibacterial activity against multidrug-resistant isolates of bacterial uropathogens in standard in-vitro condition.

scholarly journals Seeds extract of three Artocarpus species: Their in-vitro antibacterial activities against multidrug-resistant (MDR) Escherichia coli isolates from urinary tract infections (UTIs)

2021 ◽  
Vol 22 (10) ◽  
Author(s):  
Muhammad Evy Prastiyanto
Keyword(s):  
Antibacterial Activity ◽  
Urinary Tract ◽  
Urinary Tract Infections ◽  
Antibacterial Agents ◽  
Antibacterial Activities ◽  
Multidrug Resistant ◽  
E Coli ◽  
Tract Infections ◽  
Seed Extracts

Abstract. Prastiyanto ME. 2021. Seeds extract of three Artocarpus species: Their in-vitro antibacterial activities against multidrug-resistant (MDR) Escherichia coli isolates from urinary tract infections (UTIs). Biodiversitas 22: 4362-4368. Multidrug-resistant (MDR)-E. coli is a major cause and has become a very serious problem in urinary tract infections (UTIs). As a result, it requires an antibacterial agent derived from biological materials. It has been reported that the seeds of three species of Artocarpus (A. heterophyllous, A. champeden, and A. camansi) have antibacterial properties against Methicillin-Resistant Staphylococcus aureus (MRSA). However, there are three other Artocarpus species in Indonesia, i.e., keledang (A. lanceipolius), tarra (A. elasticus), and terap (A. Odoratissimus) whose antibacterial property has not been investigated. To minimize the research gap, this study aims to determine the antibacterial activity of seed extracts of A. lanceipolius, A. elasticus, and A. odoratissimus against MDR-E. coli isolates of UTIs. Antibacterial activity was evaluated using the agar well diffusion assay. The microdilution method was used to determine the minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) values. The results revealed that the seed extracts of A. lanceipolius, A. elasticus, and A. odoratissimus have the potential as antibacterial agents against MDR-E. coli isolate of UTIs. A. elasticus seed extract shows the widest zone of inhibition in the range of 7.0-13.3 mm and the smallest MIC and MBC values ??of 6.25-12.5 mg/mL and 12.5-25 mg/mL, respectively. In conclusion, A. lanceipolius, A. elasticus, and A. odoratissimus seed extracts have the potential to be developed as antibacterial agents against UTI-causing MDR-E. coli. Further in vivo research and determining the mode of action of antibacterial activity are needed.

Antibacterial activity of garlic extract and silver Nanoparticles: an in vitro analysis

2019 ◽  
Vol 10 (1) ◽  
Author(s):  
SHREYASHI M ◽  
SULAGNA D ◽  
SANKARI D ◽  
THIRUMURUGAN D ◽  
INFANT SANTHOSE B ◽  
...  
Keyword(s):  
Silver Nanoparticles ◽  
Antibacterial Activity ◽  
Garlic Extract ◽  
Vitro Analysis ◽  
In Vitro Analysis

scholarly journals Silver Nanoparticles and Their Antibacterial Applications

2021 ◽  
Vol 22 (13) ◽  
pp. 7202
Author(s):  
Tamara Bruna ◽  
Francisca Maldonado-Bravo ◽  
Paul Jara ◽  
Nelson Caro
Keyword(s):  
Silver Nanoparticles ◽  
Antibacterial Agents ◽  
Multidrug Resistant ◽  
Secondary Effects ◽  
Cytotoxic Effects ◽  
Factors Affecting ◽  
Gram Positive Bacteria ◽  
Resistant Strains

Silver nanoparticles (AgNPs) have been imposed as an excellent antimicrobial agent being able to combat bacteria in vitro and in vivo causing infections. The antibacterial capacity of AgNPs covers Gram-negative and Gram-positive bacteria, including multidrug resistant strains. AgNPs exhibit multiple and simultaneous mechanisms of action and in combination with antibacterial agents as organic compounds or antibiotics it has shown synergistic effect against pathogens bacteria such as Escherichia coli and Staphylococcus aureus. The characteristics of silver nanoparticles make them suitable for their application in medical and healthcare products where they may treat infections or prevent them efficiently. With the urgent need for new efficient antibacterial agents, this review aims to establish factors affecting antibacterial and cytotoxic effects of silver nanoparticles, as well as to expose the advantages of using AgNPs as new antibacterial agents in combination with antibiotic, which will reduce the dosage needed and prevent secondary effects associated to both.

scholarly journals The Antibacterial Activity of Human Amniotic Membrane against Multidrug-Resistant Bacteria Associated with Urinary Tract Infections: New Insights from Normal and Cancerous Urothelial Models

Biomedicines ◽  
2021 ◽  
Vol 9 (2) ◽  
pp. 218
Author(s):  
Taja Železnik Ramuta ◽  
Larisa Tratnjek ◽  
Aleksandar Janev ◽  
Katja Seme ◽  
Marjanca Starčič Erjavec ◽  
...  
Keyword(s):  
Antibacterial Activity ◽  
Urinary Tract ◽  
Urinary Tract Infections ◽  
Amniotic Membrane ◽  
Multidrug Resistant ◽  
Basic Knowledge ◽  
Resistant Bacteria ◽  
Human Amniotic Membrane ◽  
Multidrug Resistant Bacteria ◽  
Tract Infections

Urinary tract infections (UTIs) represent a serious global health issue, especially due to emerging multidrug-resistant UTI-causing bacteria. Recently, we showed that the human amniotic membrane (hAM) could be a candidate for treatments and prevention of UPEC and Staphylococcus aureus infections. However, its role against multidrug-resistant bacteria, namely methicillin-resistant S. aureus (MRSA), extended-spectrum beta-lactamases (ESBL) producing Escherichia coli and Klebsiella pneumoniae, vancomycin-resistant Enterococci (VRE), carbapenem-resistant Acinetobacter baumannii, and Pseudomonas aeruginosa has not yet been thoroughly explored. Here, we demonstrate for the first time that the hAM homogenate had antibacterial activity against 7 out of 11 tested multidrug-resistant strains, the greatest effect was on MRSA. Using novel approaches, its activity against MRSA was further evaluated in a complex microenvironment of normal and cancerous urinary bladder urothelia. Even short-term incubation in hAM homogenate significantly decreased the number of bacteria in MRSA-infected urothelial models, while it did not affect the viability, number, and ultrastructure of urothelial cells. The hAM patches had no antibacterial activity against any of the tested strains, which further exposes the importance of the hAM preparation. Our study substantially contributes to basic knowledge on the antibacterial activity of hAM and reveals its potential to be used as an antibacterial agent against multidrug-resistant bacteria.

scholarly journals 1293. Sulbactam-durlobactam is active against recent, multi-drug resistant Acinetobacter baumannii clinical isolates from the Middle East

2020 ◽  
Vol 7 (Supplement_1) ◽  
pp. S662-S662
Author(s):  
Alita Miller ◽  
Sarah McLeod ◽  
Samir Moussa ◽  
Meredith Hackel
Keyword(s):  
Antibacterial Activity ◽  
Middle East ◽  
Acinetobacter Baumannii ◽  
United Arab Emirates ◽  
Blood Stream ◽  
Multidrug Resistant ◽  
Clinical Isolates ◽  
Surveillance Systems ◽  
Spectrum Activity

Abstract Background The incidence of infections caused by multidrug-resistant (MDR) Acinetobacter baumannii (Ab) is increasing at an alarming rate in certain regions of the world, including the Middle East. Sulbactam (SUL) has intrinsic antibacterial activity against Ab; however, the prevalence of β-lactamases in Ab has limited its therapeutic utility. Durlobactam (DUR, formerly ETX2514) is a diazabicyclooctenone β-lactamase inhibitor with broad-spectrum activity against Ambler class A, C and D β-lactamases that restores SUL activity in vitro against MDR Ab. SUL-DUR is an antibiotic designed to treat serious infections caused by Acinetobacter, including multidrug-resistant strains, that is currently in Phase 3 clinical development. In global surveillance studies of >3600 isolates from 2012-2017, the MIC90 of SUL-DUR was 2 mg/L. Although surveillance systems to monitor MDR infections in the Middle East are currently being established, quantitative, prevalence-based data are not yet available. Therefore, the potency of SUL-DUR was determined against 190 recent, diverse Ab clinical isolates from this region. Methods 190 Ab isolates were collected between 2016 - 2018 from medical centers located in Israel (N = 47), Jordan (N = 36), Qatar (N = 13), Kuwait (N = 42), Lebanon (N = 8), Saudi Arabia (N = 24) and United Arab Emirates (N = 20). Seventy-five percent and 20.5% of these isolates were from respiratory and blood stream infections, respectively. Susceptibility to SUL-DUR and comparator agents was performed according to CLSI guidelines, and data analysis was performed using CLSI and EUCAST breakpoint criteria where available. Results This collection of isolates was 86% carbapenem-resistant and 90% sulbactam-resistant (based on a breakpoint of 4 mg/L). The addition of SUL-DUR (fixed at 4 mg/L) decreased the sulbactam MIC90 from 64 mg/L to 4 mg/L. Only 3 isolates (1.6%) had SUL-DUR MIC values of > 4 mg/L. This potency was consistent across countries, sources of infection and subsets of resistance phenotypes. Conclusion SUL-DUR demonstrated potent antibacterial activity against recent clinical isolates of Ab from the Middle East, including MDR isolates. These data support the global development of SUL-DUR for the treatment of MDR Ab infections. Disclosures Alita Miller, PhD, Entasis Therapeutics (Employee) Sarah McLeod, PhD, Entasis Therapeutics (Employee) Samir Moussa, PhD, Entasis Therapeutics (Employee)

scholarly journals Comparison of methods to detect the in vitro activity of silver nanoparticles (AgNP) against multidrug resistant bacteria

2015 ◽  
Vol 13 (1) ◽  
Author(s):  
Emerson Danguy Cavassin ◽  
Luiz Francisco Poli de Figueiredo ◽  
José Pinhata Otoch ◽  
Marcelo Martins Seckler ◽  
Roberto Angelo de Oliveira ◽  
...  
Keyword(s):  
Silver Nanoparticles ◽  
Multidrug Resistant ◽  
Vitro Activity ◽  
Resistant Bacteria ◽  
Comparison Of Methods ◽  
In Vitro Activity ◽  
Multidrug Resistant Bacteria

scholarly journals Antibiofilm and antivirulence potential of silver nanoparticles against multidrug-resistant Acinetobacter baumannii

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Helal F. Hetta ◽  
Israa M. S. Al-Kadmy ◽  
Saba Saadoon Khazaal ◽  
Suhad Abbas ◽  
Ahmed Suhail ◽  
...  
Keyword(s):  
Silver Nanoparticles ◽  
Antibacterial Activity ◽  
Acinetobacter Baumannii ◽  
Biofilm Formation ◽  
Microtiter Plate ◽  
Diffusion Method ◽  
Resistance Pattern ◽  
Infection Model ◽  
The Impact

AbstractWe aimed to isolate Acinetobacter baumannii (A. baumannii) from wound infections, determine their resistance and virulence profile, and assess the impact of Silver nanoparticles (AgNPs) on the bacterial growth, virulence and biofilm-related gene expression. AgNPs were synthesized and characterized using TEM, XRD and FTIR spectroscopy. A. baumannii (n = 200) were isolated and identified. Resistance pattern was determined and virulence genes (afa/draBC, cnf1, cnf2, csgA, cvaC, fimH, fyuA, ibeA, iutA, kpsMT II, PAI, papC, PapG II, III, sfa/focDE and traT) were screened using PCR. Biofilm formation was evaluated using Microtiter plate method. Then, the antimicrobial activity of AgNPs was evaluated by the well-diffusion method, growth kinetics and MIC determination. Inhibition of biofilm formation and the ability to disperse biofilms in exposure to AgNPs were evaluated. The effect of AgNPs on the expression of virulence and biofilm-related genes (bap, OmpA, abaI, csuA/B, A1S_2091, A1S_1510, A1S_0690, A1S_0114) were estimated using QRT-PCR. In vitro infection model for analyzing the antibacterial activity of AgNPs was done using a co-culture infection model of A. baumannii with human fibroblast skin cell line HFF-1 or Vero cell lines. A. baumannii had high level of resistance to antibiotics. Most of the isolates harbored the fimH, afa/draBC, cnf1, csgA and cnf2, and the majority of A. baumannii produced strong biofilms. AgNPs inhibited the growth of A. baumannii efficiently with MIC ranging from 4 to 25 µg/ml. A. baumannii showed a reduced growth rate in the presence of AgNPs. The inhibitory activity and the anti-biofilm activity of AgNPs were more pronounced against the weak biofilm producers. Moreover, AgNPs decreased the expression of kpsMII , afa/draBC,bap, OmpA, and csuA/B genes. The in vitro infection model revealed a significant antibacterial activity of AgNPs against extracellular and intracellular A. baumannii. AgNPs highly interrupted bacterial multiplication and biofilm formation. AgNPs downregulated the transcription level of important virulence and biofilm-related genes. Our findings provide an additional step towards understanding the mechanisms by which sliver nanoparticles interfere with the microbial spread and persistence.

Sign in / Sign up

Export Citation Format

Share Document